ArticleFrontiers in pharmacology2026
Dissociation between gut microbiota remodeling and early gut-liver injury in CLP-induced sepsis.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sepsis is a life-threatening condition in which early host responses critically determine organ dysfunction, yet strategies targeting this critical window remain limited. We investigated whether pre-septic modulation of host metabolism and gut microbiota could mitigate early organ injury in severe polymicrobial sepsis. Methods: Male Sprague-Dawley rats were pretreated for 4 weeks and then subjected to cecal ligation and perforation (CLP). Outcomes were assessed within the first 24 h after sepsis induction, with survival monitored for 7 days. Gut microbiota composition was analyzed at the group level before and after CLP. Results: Early sepsis was characterized by adrenal catecholamine depletion, ileal villus shortening, colonic inflammatory activation, rapid gut microbiota restructuring, and hepatic oxidative stress with selective inflammatory transcriptional activation. Although pretreatments altered baseline gut microbiota composition and partially preserved commensal and short-chain fatty acid-associated taxa, they did not improve survival nor prevent early intestinal and hepatic injury. Early mortality occurred exclusively in meldonium-pretreated animals, indicating a potential trade-off of metabolic preconditioning under severe septic stress. Despite pretreatment-specific modulation of selected antioxidant enzymes, hepatic redox imbalance and stress-associated protein oxidation persisted during early sepsis. Discussion: Collectively, these observations indicate an apparent dissociation at the group level between gut microbiota remodeling and early gut-liver injury. The first 24 h after sepsis onset thus emerge as a period of limited pharmacological plasticity, underscoring the need for therapeutic strategies that directly target the robust, systemic, host-driven stress mechanisms predominating during this early phase in severe sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.